(Q73000038)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11004733%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Economic impact of using mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11004733%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

1 reference

J Borghi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11004733%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J F Guest

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11004733%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11004733%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11004733%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11004733%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11004733%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

378-387

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11004733%20AND%20SRC:MED&resulttype=core&format=json

Mirtazapine is more effective than trazodone

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900506-X

7 January 2021

Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900506-X

7 January 2021

A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900506-X

7 January 2021

The cost of treatment dropout in depression. A cost-benefit analysis of fluoxetine vs. tricyclics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900506-X

7 January 2021

The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900506-X

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900506-X

7 January 2021

The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900506-X

7 January 2021

Economic impact of using clodronate in the management of patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900506-X

7 January 2021

The need for pharmacoeconomic evaluations in the NHS.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900506-X

7 January 2021

Cross-national epidemiology of major depression and bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900506-X

7 January 2021

Choosing an antidepressant: effectiveness based pharmacoeconomics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900506-X

7 January 2021

Economic analysis of treating depression with nefazodone v. imipramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900506-X

7 January 2021

Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in austria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900506-X

7 January 2021

Economic comparisons of the pharmacotherapy of depression: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900506-X

7 January 2021

10.1016/S0924-9338(00)00506-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11004733%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference